Japan Lifeline

Japan Lifeline is a leading commercial-stage medical device company specializing in the development, manufacture, and distribution of cardiovascular and electrophysiology products. Its own products account for approximately half of total sales, with market leadership in the ablation catheter market and a strong presence in Japan for cardiac rhythm management and vascular grafts. The company also provides interventional solutions for gastrointestinal and neurovascular diseases. Clinical milestones include successful product launches and regulatory approvals such as the Shock AT atrial cardioversion system, which received broad clinical acceptance in Japan.[1][2][4][5]